Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019-2024

Published by Frost & Sullivan Product code 955675
Published Content info 35 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019-2024
Published: August 21, 2020 Content info: 35 Pages
Description

Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities

In this research deliverable, Frost & Sullivan's analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact.

This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020-2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.

Research Highlights:

  • Pre-/post-COVID-19 impact and growth trajectory of the CRO market
  • Future market outlook and underlying trends
  • Major growth opportunities
Table of Contents
Product Code: PB21-52

Table of Contents

Growth Environment

  • Revised State of the CRO Market Due to the Pandemic
  • Key Forecast Criteria
  • Scope and Segmentation
  • Total Market Revenue Forecast
  • Total Market Revenue Forecast-Original and Revised Forecast Comparison
  • Drug Discovery and Preclinical CRO Revenue Forecast
  • Drug Discovery and Preclinical CRO Market-Post-COVID-19 Revenue Scenario
  • Clinical Segment Revenue Forecast
  • Distribution of Disrupted Trial Sites
  • COVID-19 Trials by Regions and Phases
  • Disrupted Trials-Discussion
  • Revenue Forecast by Peripheral Segments
  • Other Forecast Trends
  • Policy and Regulations
  • Policy and Regulations (continued)
  • Policy and Regulations (continued)
  • Global CRO Market Future Outlook
  • Global CRO Market Future Outlook (Continued)

Growth Opportunities

  • Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019
  • Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019 (continued)
  • Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019
  • Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019 (continued)
  • Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019
  • Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019 (continued)

Appendix: Growth Pipeline Engine™

  • About the Growth Pipeline Engine™
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer
Back to Top